Journal of Cellular and Molecular Medicine

Papers
(The H4-Index of Journal of Cellular and Molecular Medicine is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Information195
Up‐regulation ofPRKDCwas associated with poor renal dysfunction after renal transplantation: A multi‐centre analysis119
Exploring the immune escape mechanisms in gastric cancer patients based on the deep AI algorithms and single‐cell sequencing analysis103
Anti‐Inflammatory Resveratrol Protects Mice From Early Mortality After Haematopoietic Stem Cell Transplantation97
Increased Matrix Stiffness Promotes Slow Muscle Fibre Regeneration After Skeletal Muscle Injury94
BDA‐410 inhibits SARS‐CoV‐2 main protease activity and viral replication in mammalian cells90
CircularRNA Hsa_circ_0093335 promotes hepatocellular carcinoma progression via sponging miR‐338‐5p89
Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer83
Issue Information66
Design of multi‐epitope chimeric vaccine against Monkeypox virus and SARS‐CoV‐2: A vaccinomics perspective64
Correction to RDM1 promotes critical processes in breast cancer tumorigenesis63
Efficacy and Safety of Combining r‐ ATG With PTCy for GvHD 63
Correction to “The Uyghur Population and Genetic Susceptibility to Type 2 Diabetes: Potential Role for Variants in CAPN10 , 59
Application of T‐cell receptor repertoire as a novel monitor in dynamic tracking and assessment: A cohort‐study based on RA patients58
Puerarin Protects Myocardium From Ischaemia/Reperfusion Injury by Inhibiting Ferroptosis Through Downregulation of VDAC155
GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer52
Antitumor effect and metabonomics of niclosamide micelles50
CTSC Confers Radioresistance in Hepatocellular Carcinoma by Regulating Myeloid‐Derived Suppressor Cells49
Potential Role of High‐Intensity Interval Training‐Induced Increase in Humanin Levels for the Management of Type 2 Diabetes48
Integration of Single‐Cell RNA Sequencing Data and Bulk Sequencing Data to Characterise the CD8 + T‐Cell Exhaustion Mediated Immune Microenvironment 48
Apocynin exerts cytoprotective effects on dexamethasone‐induced osteoblasts by inhibiting oxidative stress through the Nrf2 signalling pathway47
RETRACTION : Long Non‐Coding RNA FEZF1 ‐ AS1 Induced Progression of46
Identification of hypoxia‐related gene signatures based on multi‐omics analysis in lung adenocarcinoma46
Potential role of long non‐coding RNA H19 and Neat1 in haemophilic arthropathy43
Single‐Cell Transcriptomic Reveals the Involvement of Cell–Cell Junctions in the Early Development of Hypertrophic Cardiomyopathy43
Ephedrine Attenuates LPS‐Induced Acute Lung Injury in Mice by Inhibiting OTUB1 and Promoting K48 Ubiquitination of HIF1α42
Unveiling the Role of PNMA2 in Endometriosis: From Proliferation and Apoptosis to Immunomodulation42
42
ANS‐SCMC: A matrix completion method based on adaptive neighbourhood similarity and sparse constraints for predicting microbe‐disease associations41
Genetic interactions and pleiotropy in metabolic diseases: Insights from a comprehensive GWAS analysis41
KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down‐regulating SERTAD440
Inhibitory Effect of Amentoflavone on the Virulence of MRSA by Targeting ClpP40
WKYMVm ameliorates obesity by improving lipid metabolism and leptin signalling38
Calycosin alleviates titanium particle‐induced osteolysis by modulating macrophage polarization and subsequent osteogenic differentiation38
Construction of a Prognostic Model Using RNA Processing Factor Genes and the Key Role of NSUN6 in Glioma Outcomes37
Cannabidiol Is a Potential Inhibitor of Ferroptosis in Human Articular Chondrocytes37
Amentoflavone reverses epithelial‐mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis37
0.092107057571411